1. Home
  2. SBFM vs DUO Comparison

SBFM vs DUO Comparison

Compare SBFM & DUO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SBFM
  • DUO
  • Stock Information
  • Founded
  • SBFM 2006
  • DUO 2011
  • Country
  • SBFM United States
  • DUO China
  • Employees
  • SBFM N/A
  • DUO N/A
  • Industry
  • SBFM Biotechnology: Pharmaceutical Preparations
  • DUO Real Estate
  • Sector
  • SBFM Health Care
  • DUO Finance
  • Exchange
  • SBFM Nasdaq
  • DUO Nasdaq
  • Market Cap
  • SBFM 6.7M
  • DUO 6.1M
  • IPO Year
  • SBFM N/A
  • DUO 2019
  • Fundamental
  • Price
  • SBFM $1.67
  • DUO $3.42
  • Analyst Decision
  • SBFM Strong Buy
  • DUO
  • Analyst Count
  • SBFM 1
  • DUO 0
  • Target Price
  • SBFM $15.00
  • DUO N/A
  • AVG Volume (30 Days)
  • SBFM 62.2K
  • DUO 1.1M
  • Earning Date
  • SBFM 11-04-2025
  • DUO 11-19-2025
  • Dividend Yield
  • SBFM N/A
  • DUO N/A
  • EPS Growth
  • SBFM N/A
  • DUO N/A
  • EPS
  • SBFM N/A
  • DUO N/A
  • Revenue
  • SBFM $36,341,741.00
  • DUO $56,189,313.00
  • Revenue This Year
  • SBFM $32.20
  • DUO N/A
  • Revenue Next Year
  • SBFM $32.74
  • DUO N/A
  • P/E Ratio
  • SBFM N/A
  • DUO N/A
  • Revenue Growth
  • SBFM 19.22
  • DUO 48.30
  • 52 Week Low
  • SBFM $1.17
  • DUO $1.24
  • 52 Week High
  • SBFM $3.90
  • DUO $37.44
  • Technical
  • Relative Strength Index (RSI)
  • SBFM 67.82
  • DUO 54.05
  • Support Level
  • SBFM $1.50
  • DUO $3.03
  • Resistance Level
  • SBFM $1.67
  • DUO $3.78
  • Average True Range (ATR)
  • SBFM 0.08
  • DUO 0.43
  • MACD
  • SBFM 0.01
  • DUO -0.08
  • Stochastic Oscillator
  • SBFM 73.44
  • DUO 34.58

About SBFM Sunshine Biopharma Inc.

Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.

About DUO Fangdd Network Group Ltd.

Fangdd Network Group Ltd is an investment holding company. It is engaged in the provision of real estate information services through its online platform which also offers integrated marketing services for individual customers, real estate developers, and agents in China. Its SaaS-based solutions help real estate agents to connect with essential business resources, including customers, property listings, capital, and transaction data. The company generates the majority of its revenue from Base commission from transactions in China.

Share on Social Networks: